| 000 | 01837 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250514223730.0 | ||
| 264 | 0 | _c20050921 | |
| 008 | 200509s 0 0 eng d | ||
| 022 | _a0006-4971 | ||
| 024 | 7 |
_a10.1182/blood-2004-05-2017 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSloand, Elaine M | |
| 245 | 0 | 0 |
_aPreferential suppression of trisomy 8 compared with normal hematopoietic cell growth by autologous lymphocytes in patients with trisomy 8 myelodysplastic syndrome. _h[electronic resource] |
| 260 |
_bBlood _cAug 2005 |
||
| 300 |
_a841-51 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntilymphocyte Serum _xtherapeutic use |
| 650 | 0 | 4 | _aAutoimmunity |
| 650 | 0 | 4 | _aBone Marrow Cells |
| 650 | 0 | 4 |
_aCD8-Positive T-Lymphocytes _ximmunology |
| 650 | 0 | 4 | _aCell Proliferation |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChromosomes, Human, Pair 8 |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHematopoietic Stem Cells _xcytology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMyelodysplastic Syndromes _xdrug therapy |
| 650 | 0 | 4 |
_aReceptors, Antigen, T-Cell, alpha-beta _xanalysis |
| 650 | 0 | 4 | _aT-Cell Antigen Receptor Specificity |
| 650 | 0 | 4 |
_aT-Lymphocytes, Cytotoxic _ximmunology |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aTrisomy |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 700 | 1 | _aMainwaring, Lori | |
| 700 | 1 | _aFuhrer, Monika | |
| 700 | 1 | _aRamkissoon, Shakti | |
| 700 | 1 | _aRisitano, Antonio M | |
| 700 | 1 | _aKeyvanafar, Keyvan | |
| 700 | 1 | _aLu, Jun | |
| 700 | 1 | _aBasu, Atanu | |
| 700 | 1 | _aBarrett, A John | |
| 700 | 1 | _aYoung, Neal S | |
| 773 | 0 |
_tBlood _gvol. 106 _gno. 3 _gp. 841-51 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1182/blood-2004-05-2017 _zAvailable from publisher's website |
| 999 |
_c15495883 _d15495883 |
||